InChI
1S/C27H36F2O6/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-24(18,5)26(17,29)20(31)12-25(16,6)27(14,34)21(32)13-35-22(33)23(2,3)4/h7-8,10,14,16-17,19-20,31,34H,9,11-13H2,1-6H3/t14-,16+,17+,19+,20+,24+,25+,26+,27+/m1/s1
InChI key
JWRMHDSINXPDHB-OJAGFMMFSA-N
SMILES string
[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C
form
solid
optical activity
[α]25/D 71.0 to 82.0°, c = 1 in dioxane
solubility
dioxane: 4.0 mL, clear, colorless to very faintly yellow (50 mg + 4.0 mL dioxane)
mode of action
cell membrane | interferes
Gene Information
human ... NR3C1(2908)
正在寻找类似产品? 访问 产品对比指南
Application
Flumethasone pivalate is a topical difluorinated corticosteroid ester with anti-inflammatory, antipruritic and vasoconstrictive properties. A prompt decrease in inflammation, exudation and itching is experienced after application. It is used to study adrenocortical suppression, plasma transcortin binding, and cutaneous atrophy and telangiectasia.
Biochem/physiol Actions
Flumethasone pivalate is a glucocorticoid receptor agonist used in studies on plasma transcortin binding. It binds to the nucleus causing a variety of genetic activations and repressions. The anti-inflammatory action of flumethasone is thought to involve lipocortins and phospholipase A2 inhibitory proteins, which results in the inhibition of arachidonic acid and the control of prostaglandin and leukotriene biosynthesis. Flumethasone suppresses the immune system due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.
signalword
Warning
hcodes
Hazard Classifications
Carc. 2
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
法规信息
涉药品监管产品
此项目有
Adrenocortical Suppression With Topical Flumethasone
Richard D. Carr and Ralph G. Wieland
Archives of Dermatological Research, 96, 269-272 (1967)
T Hojyo
The Journal of international medical research, 15(5), 255-263 (1987-09-01)
The combination creams, betamethasone dipropionate/clotrimazole/gentamicin sulphate and flumethasone pivalate/clioquinol, were compared in patients with corticosteroid responsive dermatoses and/or cutaneous fungal and/or bacterial infections. Medication was applied to affected areas twice daily for 28 days. Of 67 patients enrolled, 31 treated
Corticosteroid-Induced Cutaneous Atrophy and Telangiectasia: Experimental Production Associated With Weight Loss in Rats
. Graham Smith, Jr, Richard F. Wehr, et al.
Archives of Dermatological Research, 112, 1115-1117 (1976)
[Release of flumethasone pivalate from oleogel and W/O emulsion bases in vitro].
W Horsch et al.
Die Pharmazie, 37(11), 807-808 (1982-11-01)
[Biological changes in the skin].
M L Fica Hernando
Revista de enfermeria (Barcelona, Spain), 14(153), 77-79 (1991-05-01)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持